Lexicon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. 

CEO
Michael Exton
CEOMichael Exton
Employees
81
Employees81
Headquarters
The Woodlands, Texas
HeadquartersThe Woodlands, Texas
Founded
1995
Founded1995
Employees
81
Employees81

LXRX Key Statistics

Market cap
1.10B
Market cap1.10B
Price-Earnings ratio
-33.01
Price-Earnings ratio-33.01
Dividend yield
Dividend yield
Average volume
2.99M
Average volume2.99M
High today
$2.47
High today$2.47
Low today
$1.94
Low today$1.94
Open price
$1.98
Open price$1.98
Volume
4.89M
Volume4.89M
52 Week high
$2.68
52 Week high$2.68
52 Week low
$1.02
52 Week low$1.02

Stock Snapshot

The current Lexicon Pharmaceuticals(LXRX) stock price is $2.34, with a market capitalization of 1.1B. The stock trades at a price-to-earnings (P/E) ratio of -33.01.

On 2026-08-07, Lexicon Pharmaceuticals(LXRX) stock moved within a range of $1.94 to $2.47. With shares now at $2.34, the stock is trading +20.6% above its intraday low and -5.2% below the session's peak.

Trading volume for Lexicon Pharmaceuticals(LXRX) stock has reached 4.89M, versus its average volume of 2.99M.

Over the past 52 weeks, Lexicon Pharmaceuticals(LXRX) stock has traded between a high of $2.68 and a low of $1.02.

Over the past 52 weeks, Lexicon Pharmaceuticals(LXRX) stock has traded between a high of $2.68 and a low of $1.02.

LXRX News

Simply Wall St 2d
Why Lexicon Pharmaceuticals Is Up 6.4% After Completing Randomization in Pivotal SONATA-HCM Trial

Lexicon Pharmaceuticals recently reported completion of patient randomization in its pivotal Phase 3 SONATA-HCM trial of sotagliflozin for both obstructive and...

Why Lexicon Pharmaceuticals Is Up 6.4% After Completing Randomization in Pivotal SONATA-HCM Trial

People also own

Based on the portfolios of people who own LXRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.